Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells.
Luteolin inhibits Musashi1 binding to RNA and disrupts cancer phenotypes in glioblastoma cells. RNA Biol. 2018; 15(11):1420-1432.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Cell Line, Tumor
Cell Proliferation
Cell Survival
Combined Modality Therapy
Gene Expression Regulation, Neoplastic
Glioblastoma
Humans
Luteolin
Nerve Tissue Proteins
Phenotype
Phthalazines
Piperazines
Radiation, Ionizing
RNA
RNA-Binding Proteins
Small Molecule Libraries
authors with profiles
Matthew J Hart